News
Clinical Data Studio has supported 465 global studies since its launch in 2024, reducing data review cycles by up to 80% and ...
Centene withdrew its previous 2025 earnings guidance and all underlying guidance elements based on the company's preliminary ...
The transition from writing to programming regulatory submissions represents one of the most significant efficiency ...
2d
Stocktwits on MSNSunshine Biopharma Stock Soars After Launch Of First Biosimilar In $10B Canadian Market: Retail Bulls Charge InRetail chatter around Sunshine Biopharma surged late Wednesday after the company introduced Niopeg, its first biosimilar drug ...
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel” or the 'Company”), a biopharmaceutical company ...
Vor Biopharma gains rights to autoimmune drug telitacicept, raises capital and names a new CEO in a major strategic reset.
ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it ...
Arsenale Bioyards recognized the inefficiencies and developed a platform that could radically change biomanufacturing, much like the Bessemer converter in the mid-19th century transformed the steel ...
Yili Modern Intelligent Health Valley in Hohhot City, north China's Inner Mongolia Autonomous Region. Photo:Xinhua. As a str ...
We'll still need healthcare products and services in the future, whether we're talking about 10 or 100 years from now. The ...
In an open letter addressing the Trump administration's proposed budget cuts to HHS, the executives urged Congress to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results